The U.S. Court of Appeals for the Federal Circuit's decision in In re Healy offers another data point in the ongoing challenge of patenting ...
Recently, exciting news came from the 2025 Canada iCAN International Invention Innovation Competition Thankcome's independently developed "AKK PROBIO Functional Strain and Industrial Application ...
When one recently went up for auction, it sold for an eye-watering $12.1 million (£9.3m). The spectacular loo is an artwork ...
Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of oncology and immunotherapy products. The Company’s mission is to address high-unmet-need ...
The importance of minority-interest remeasurement has expanded as joint venture and platform-licensing models become more common in biotech. For investors, such metrics provide an improved lens for ...
At La Galerie Dior in Paris, “Alaïa’s Dior Collection” showcases 140 Dior couture pieces collected by the Tunisian couturier ...
Oncotelic Therapeutics, Inc. (OTLC) today announces that its joint venture partner, GMP Bio, has completed an independent third-party valuation ...
Opening tomorrow at La Galerie Dior in Paris, “Alaïa’s Dior Collection” is essentially the story of how one couturier ...
Jointly organised by the HKSAR Government and the Hong Kong Trade Development Council (HKTDC), the 15th Business of IP Asia Forum (BIP Asia Forum) will be held on 4–5 December at the Hong Kong ...